PRESS RELEASE published on 02/21/2025 at 08:30, 1 year 2 months ago Abivax organisera un webcast animé par un leader d’opinion de renom le 17 mars 2025 Abivax organisera un webcast animé par un leader d’opinion de renom le 17 mars 2025. Le Dr David Rubin présentera l’essai clinique pivot de phase 3 ABTECT d’Abivax Abivax Webcast Essai Clinique Phase 3 Dr David Rubin
BRIEF published on 02/18/2025 at 10:08, 1 year 2 months ago Franchissement de seuil chez ABIVAX : déclaration de Sofinnova Droits De Vote Franchissement De Seuil Abivax Développement De Produits Sofinnova Partners
BRIEF published on 02/18/2025 at 10:08, 1 year 2 months ago Crossing of threshold at ABIVAX: statement from Sofinnova Voting Rights Abivax Threshold Crossing Product Development Sofinnova Partners
PRESS RELEASE published on 02/18/2025 at 10:03, 1 year 2 months ago Franchissement de seuil et déclaration d'intention Déclaration de franchissement de seuil et déclaration d'intention par Sofinnova Partners pour ABIVAX sur Euronext Paris Euronext Paris Franchissement De Seuil Abivax Déclaration D'intention Sofinnova Partners
BRIEF published on 01/28/2025 at 08:35, 1 year 3 months ago Abivax dévoile son calendrier financier pour 2025 Résultats Financiers Biotechnologie Calendrier Financier Abivax Rapport Semestriel
BRIEF published on 01/28/2025 at 08:35, 1 year 3 months ago Abivax unveils its financial calendar for 2025 Financial Results Biotechnology Half-yearly Report Financial Calendar Abivax
PRESS RELEASE published on 01/28/2025 at 08:30, 1 year 3 months ago Abivax publie son calendrier financier 2025 Abivax publie son calendrier financier 2025 incluant diverses communications clés pour l'année, notamment résultats financiers et assemblée générale Résultats Financiers Communication Financière Calendrier Financier Abivax Investisseurs
PRESS RELEASE published on 01/28/2025 at 08:30, 1 year 3 months ago Abivax publie son calendrier financier 2025 Abivax publie son calendrier financier 2025. La société de biotechnologie spécialisée dans les maladies inflammatoires chroniques dévoile son planning financier pour l'année en cours Communication Financière Biotechnologie Calendrier Financier Abivax Maladies Inflammatoires Chroniques
PRESS RELEASE published on 01/28/2025 at 08:30, 1 year 3 months ago Abivax Publishes 2025 Financial Calendar Abivax publishes its 2025 financial calendar, detailing key financial communications throughout the year. The company is focused on developing therapies for chronic inflammatory diseases Biotechnology Abivax Therapeutics Chronic Inflammatory Diseases 2025 Financial Calendar
BRIEF published on 01/27/2025 at 18:05, 1 year 3 months ago ABIVAX : Mise à jour sur les actions et droits de vote au 31 décembre 2024 Droits De Vote Capital Social Actions Abivax Transparence Financière
Published on 05/08/2026 at 01:50, 3 hours 8 minutes ago Apex Critical Metals Announces Grant of Stock Options and RSUs
Published on 05/08/2026 at 00:45, 4 hours 13 minutes ago Route1 Announces First Quarter 2026 Financial Results Notification
Published on 05/08/2026 at 00:00, 4 hours 58 minutes ago Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 5 hours 28 minutes ago Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 5 hours 43 minutes ago BULGOLD Adopts Semi-Annual Financial Reporting
Published on 05/07/2026 at 23:23, 5 hours 35 minutes ago H1 25/26: Challenging environment and significant changes in IT market // Revised forecast // Programme to boost competitiveness
Published on 05/07/2026 at 23:14, 5 hours 44 minutes ago EQS-Adhoc: All for One Group SE revises forecast for 2025/26 financial year // »Precision« programme to boost competitiveness approved
Published on 05/07/2026 at 22:05, 6 hours 53 minutes ago Univar Solutions Announces Leadership Evolution
Published on 05/07/2026 at 20:42, 8 hours 16 minutes ago RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
Published on 05/07/2026 at 18:46, 10 hours 12 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/07/2026 at 19:15, 9 hours 43 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 9 hours 43 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 9 hours 52 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 9 hours 52 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 9 hours 58 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
